AJCN Tufts Nutrition Symposium, Boston Sept 24-26
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pellegatta, F.
Right arrow Articles by Ferrero, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pellegatta, F.
Right arrow Articles by Ferrero, M. E.
Agricola
Right arrow Articles by Pellegatta, F.
Right arrow Articles by Ferrero, M. E.
American Journal of Clinical Nutrition, Vol. 77, No. 5, 1220-1228, May 2003
© 2003 American Society for Clinical Nutrition


Original Research Communication

Different short- and long-term effects of resveratrol on nuclear factor-{kappa}B phosphorylation and nuclear appearance in human endothelial cells1,2

Fabio Pellegatta, Alberto AE Bertelli, Bart Staels, Christian Duhem, Alessandro Fulgenzi and Maria Elena Ferrero

1 From the Cardiovascular Pathophysiology Laboratory, Division of Cardiology, Istituto Scientifico Ospedale San Raffaele, Milan, Italy (FP); the Department of Human Anatomy, University of Milan, Milan, Italy (AAEB); INSERM, Institut Pasteur de Lille, Lille, France (BS and CD); and Istituto di Patologia Generale, Universitá degli Studi di Milano, Milan, Italy (AF and MEF).

Background: Resveratrol (a naturally occurring phytoalexin found in grapes and wine) has cardiovascular protective effects that suggest the antiatherogenic (ie, antiinflammatory) activities of the compound on endothelial cells.

Objective: The antiinflammatory activity of resveratrol could be mediated by its interference with nuclear factor-{kappa}B (NF-{kappa}B)–dependent transcription. Thus, we studied the in vitro influence of physiologic concentrations of resveratrol (<= 1 µmol/L) on the NF-{kappa}B signaling pathway after tumor necrosis factor {alpha} (TNF-{alpha}) stimulation of endothelial cells.

Design: The effects of a 30-min (acute) and an overnight incubation of resveratrol on the nuclear appearance of p50-NF-{kappa}B and p65-NF-{kappa}B on serine and tyrosine phosphorylation of the inhibitory subunit {kappa}B {alpha} (I{kappa}B{alpha}), cytoplasmic concentrations of I{kappa}B{alpha}, NF-{kappa}B phosphorylation or nitrosylation, the reduction of the mitotic inhibitor p21, and the activation of peroxisome proliferator–activated receptor {alpha} were evaluated.

Results: The nuclear appearance of p50-NF{kappa}B and p65-NF{kappa}B acutely induced by TNF-{alpha} was not modified by resveratrol but was increased after overnight incubation with resveratrol alone or in combination with TNF-{alpha}. Acute treatment with resveratrol did not modify TNF-{alpha}–induced cytoplasmic I{kappa}B{alpha} serine phosphorylation but did increase I{kappa}B{alpha} tyrosine phyophorylation. Resveratrol increased the tyrosine phosphorylation (but not nitrosylation) of immunoprecipitated NF-{kappa}B, did not decrease cellular p21, and did not increase peroxisome proliferator–activated receptor {alpha} activity.

Conclusions: Acute resveratrol treatment does not inhibit the nuclear appearance of NF-{kappa}B in human umbilical vein endothelial cells, but overnight treatment does. The increase in tyrosine phosphorylation of I{kappa}B{alpha}, p50-NF-{kappa}B, and p65-NF-{kappa}B suggests the involvement of such alterations in the modulation of NF-{kappa}B transcription activity.

Key Words: Resveratrol • endothelial cells • nuclear factor-{kappa}B • atherosclerosis • inflammatory disease • red wine • tumor necrosis factor {alpha}




This article has been cited by other articles:


Home page
Eur Heart JHome page
L. H. Opie and S. Lecour
The red wine hypothesis: from concepts to protective signalling molecules
Eur. Heart J., July 2, 2007; 28(14): 1683 - 1693.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Csiszar, K. Smith, N. Labinskyy, Z. Orosz, A. Rivera, and Z. Ungvari
Resveratrol attenuates TNF-{alpha}-induced activation of coronary arterial endothelial cells: role of NF-{kappa}B inhibition.
Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1694 - H1699.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S.-O. Moon, W. Kim, M. J. Sung, S. Lee, K. P. Kang, D. H. Kim, S. Y. Lee, J.-N. So, and S. K. Park
Resveratrol Suppresses Tumor Necrosis Factor-{alpha}-Induced Fractalkine Expression in Endothelial Cells
Mol. Pharmacol., July 1, 2006; 70(1): 112 - 119.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J. L. Kang, H. J. Jung, K. Lee, and H. R. Kim
Src Tyrosine Kinases Mediate Crystalline Silica-Induced NF-{kappa}B Activation through Tyrosine Phosphorylation of I{kappa}B-{alpha} and p65 NF-{kappa}B in RAW 264.7 Macrophages
Toxicol. Sci., April 1, 2006; 90(2): 470 - 477.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. E. Szmitko and S. Verma
Antiatherogenic potential of red wine: clinician update
Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2023 - H2030.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Hishikawa, T. Nakaki, and T. Fujita
Oral Flavonoid Supplementation Attenuates Atherosclerosis Development in Apolipoprotein E-Deficient Mice
Arterioscler. Thromb. Vasc. Biol., February 1, 2005; 25(2): 442 - 446.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J.-S. Choi, Y.-J. Choi, S.-H. Park, J.-S. Kang, and Y.-H. Kang
Flavones Mitigate Tumor Necrosis Factor-{alpha}-Induced Adhesion Molecule Upregulation in Cultured Human Endothelial Cells: Role of Nuclear Factor-{kappa}B
J. Nutr., May 1, 2004; 134(5): 1013 - 1019.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by The American Society for Nutrition